Skip Navigation
Menu
Letters |16 April 2002

Cardiovascular Outcomes and Renal Disease

Johannes F.E. Mann, MD; Hertzel C. Gerstein, MD; Salim Yusuf, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • The HOPE Office; McMaster University; Hamilton, Ontario L8L 2X2, Canada (Mann, Gerstein, Yusuf)
×
FULL TEXT
IN RESPONSE:
McCullough and colleagues correctly point out that patients with even mild renal insufficiency exhibit an excess of car-diovascular risk factors. Controlling for such risk factors indicated that renal insufficiency is an additional, independent risk factor. This is also evident from Table 1 of our article. Therapeutic nihilism was obviously not a problem of the HOPE study because antiplatelet, blood pressure-lowering, and cholesterol-lowering agents were, if anything, more frequently administered in patients with renal insuf-ficiency than those without.
However, we emphasize that the results of the HOPE study contradict the common practice to withhold angiotensin-converting enzyme inhibitors, including ramipril, in patients with renal insuffi-ciency. We have no evidence that patients with renal insufficiency in the HOPE study received fewer thrombolytics; invasive procedures, including revascularization (a secondary outcome of the HOPE study); or β-blockers. It is entirely possible that risk factors we did not evaluate may explain some of the increased risk associated with even mild renal insufficiency. However, current experimental and clinical evidence indicates that some aspects of renal failure may promote atherosclerosis and may be treatable. Further research into these factors is necessary, and our article was published to stimulate such investigations.
FULL TEXT
PDF
Not Available
Citations
Citation

Mann JF, Gerstein HC, Yusuf S. Cardiovascular Outcomes and Renal Disease. Ann Intern Med. 2002;136:634. doi: 10.7326/0003-4819-136-8-200204160-00021

Download citation file:

© 2018

×
Permissions

Published: Ann Intern Med. 2002;136(8):634.

DOI: 10.7326/0003-4819-136-8-200204160-00021

©
2002 American College of Physicians
0 Citations
CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×